MedPath

Determination of time and amount of hyper tonic saline required to induce a 15% FEV1 decrease in asthmatic patients referred to shahid beheshti hospita,l Kasha

Phase 2
Conditions
Asthma.
Mixed asthma
Registration Number
IRCT201104266187N2
Lead Sponsor
Kashan University of Medicine Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

asthmatic patients, age between 15 to 60 with FEV1>60%
Exclusion criteria: pneumonia; bronchectasia, advance interstitial lung disease; pulmonary fibrosis; chronic obstructive pulmonary disease and valvular & congenital heart disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
15% decrease in FEV1. Timepoint: 0.5 minute. Method of measurement: Spirometry.;15%decrease in FEV1. Timepoint: 1 minute. Method of measurement: spirometry.;15% decrease in FEV1. Timepoint: 2 minute. Method of measurement: spirometry.;15% decrease in FEV1. Timepoint: 4 minute. Method of measurement: spirometry.;15% decrease in FEV1. Timepoint: 6 minute. Method of measurement: spirometry.;15% decrease in FEV1. Timepoint: 8 minute. Method of measurement: spirometry.
Secondary Outcome Measures
NameTimeMethod
20% decrease in PEF. Timepoint: 0.5 minute. Method of measurement: spirometry.;20% decrease in PEF. Timepoint: 1 minute. Method of measurement: spirometry.;20% decrease in PEF. Timepoint: 2 minute. Method of measurement: spirometry.;20% decrease in PEF. Timepoint: 4 minute. Method of measurement: spirometry.;20% decrease in PEF. Timepoint: 6 minute. Method of measurement: spirometry.;20% decrease in PEF. Timepoint: 8 minute. Method of measurement: spirometry.
© Copyright 2025. All Rights Reserved by MedPath